Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form

Nicholas Turner; A Wells; J W Wong; P C Michels; K Fandrick; G L Finch; A Goswami; H. Lee; S Mix; T. Moody; L Pang; D. A.  Entwistle; R. K. Sato; T. J. Watson

doi:10.1021/acs.oprd.5b00369

Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form

Nicholas Turner, A Wells, J W Wong, P C Michels, K Fandrick, G L Finch, A Goswami, H. Lee, S Mix, T. Moody, L Pang, D. A. Entwistle, R. K. Sato, T. J. Watson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	3298-3306
Journal	Organic Process Research & Development
Volume	20
Issue number	3
DOIs	https://doi.org/10.1021/acs.oprd.5b00369
Publication status	Published - 9 Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/acs.oprd.5b00369

Cite this

Turner, N., Wells, A., Wong, J. W., Michels, P. C., Fandrick, K., Finch, G. L., Goswami, A., Lee, H., Mix, S., Moody, T., Pang, L., Entwistle, D. A., Sato, R. K., & Watson, T. J. (2016). Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form. Organic Process Research & Development, 20(3), 3298-3306. https://doi.org/10.1021/acs.oprd.5b00369

@article{7cfb2cbd58ad45db98afcf0f9de127ca,

title = "Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form",

author = "Nicholas Turner and A Wells and Wong, {J W} and Michels, {P C} and K Fandrick and Finch, {G L} and A Goswami and H. Lee and S Mix and T. Moody and L Pang and Entwistle, {D. A.} and Sato, {R. K.} and Watson, {T. J.}",

year = "2016",

month = feb,

day = "9",

doi = "10.1021/acs.oprd.5b00369",

language = "English",

volume = "20",

pages = "3298--3306",

journal = "Organic Process Research & Development",

issn = "1083-6160",

publisher = "American Chemical Society",

number = "3",

}

Turner, N, Wells, A, Wong, JW, Michels, PC, Fandrick, K, Finch, GL, Goswami, A, Lee, H, Mix, S, Moody, T, Pang, L, Entwistle, DA, Sato, RK & Watson, TJ 2016, 'Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form', Organic Process Research & Development, vol. 20, no. 3, pp. 3298-3306. https://doi.org/10.1021/acs.oprd.5b00369

Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form. / Turner, Nicholas; Wells, A; Wong, J W et al.
In: Organic Process Research & Development, Vol. 20, No. 3, 09.02.2016, p. 3298-3306.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form

AU - Turner, Nicholas

AU - Wells, A

AU - Wong, J W

AU - Michels, P C

AU - Fandrick, K

AU - Finch, G L

AU - Goswami, A

AU - Lee, H.

AU - Mix, S

AU - Moody, T.

AU - Pang, L

AU - Entwistle, D. A.

AU - Sato, R. K.

AU - Watson, T. J.

PY - 2016/2/9

Y1 - 2016/2/9

U2 - 10.1021/acs.oprd.5b00369

DO - 10.1021/acs.oprd.5b00369

M3 - Article

SN - 1083-6160

VL - 20

SP - 3298

EP - 3306

JO - Organic Process Research & Development

JF - Organic Process Research & Development

IS - 3

ER -